OneMedNet Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.4M | $643,000 | $1.0M | $1.2M | — |
| Cost of revenue | $1.9M | $924,000 | $1.1M | $1.5M | — |
| Gross profit | -$503,000 | -$281,000 | -$129,000 | -$360,000 | — |
| Research and development | $1.5M | $1.5M | $2.1M | $1.6M | — |
| Operating expenses | $9.2M | $9.3M | $6.7M | $7.4M | — |
| Operating income | -$9.7M | -$9.6M | -$6.9M | -$7.7M | -$585,405 |
| Interest expense | $67,000 | $147,000 | $11,000 | $403,307 | — |
| Pretax income | -$2.8M | -$10.1M | -$33.8M | -$30.4M | $5.1M |
| Income tax expense | $1,000 | $2,000 | $18,000 | $17,000 | — |
| Net income | -$2.8M | -$10.1M | -$33.8M | -$30.5M | $5.1M |
| Balance Sheet | |||||
| Cash and equivalents | $585,000 | $172,000 | $47,000 | $271,000 | $453,151 |
| Current assets | $2.1M | $3.6M | $365,000 | $391,000 | $536,212 |
| Total assets | $2.2M | $3.7M | $464,000 | $1.3M | $117.9M |
| Current liabilities | $4.8M | $19.2M | $13.8M | $26.1M | $289,980 |
| Total liabilities | $5.1M | $19.7M | $13.9M | $27.6M | $9.2M |
| Stockholders' equity | -$3.0M | -$15.9M | -$13.4M | -$26.4M | -$7.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$7.5M | -$7.0M | -$4.8M | -$4.7M | -$378,487 |
| Depreciation and amortization | $65,000 | $57,000 | $28,000 | $25,000 | — |
| Stock-based compensation | $2.0M | $628,000 | $1.5M | $1.9M | $0 |
| Capital expenditure | $13,000 | $51,000 | $44,000 | $58,000 | — |
| Free cash flow | -$7.5M | -$7.0M | -$4.8M | -$4.8M | — |
| Share repurchases | $500,000 | $529,000 | — | — | — |
| Impairments | — | — | $10.5M | — | — |
Shares outstanding 54.4M · Free float 36.5%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.